Open AccessAssociation of multiple preventive therapies postdischarge and long-term health outcomes after acute myocardial infarction
Author(s) -
ChihWei Chen,
YiCheng Lin,
Chuen Ming Shih,
WanTing Chen,
FengYen Lin,
WeiFung Bi,
Yung Ta Kao,
KuangHsing Chiang,
ChaoShun Chan,
Chien Yi Hsu,
TsungLin Yang,
Cheng-Yi Hsiao,
Bu-Yuan Hsiao,
LiNien Chien,
ChunYao Huang
Publication year - 2021
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1097/jcma.0000000000000621
Subject(s) - medicine , myocardial infarction , hazard ratio , cohort , cohort study , population , proportional hazards model , emergency medicine , intensive care medicine , confidence interval , environmental health
Statins, beta-blockers, and angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers have been advocated by guidelines as secondary prevention medications to improve the long-term outcomes of post-acute myocardial infarction (AMI) patients. However, adequate drug adherence has always been challenging, and different treatment regimens may lead to divergent outcomes that remain unclear under current myocardial infarction (MI) care standards. This study investigated the association between use of different preventive regimens post-AMI and patients' long-term outcomes.